177 related articles for article (PubMed ID: 35793738)
1. Revealing PACMA 31 as a new chemical type TrxR inhibitor to promote cancer cell apoptosis.
Xu Q; Zhang J; Zhao Z; Chu Y; Fang J
Biochim Biophys Acta Mol Cell Res; 2022 Oct; 1869(10):119323. PubMed ID: 35793738
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Thioredoxin System for Cancer Therapy.
Zhang J; Li X; Han X; Liu R; Fang J
Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527
[TBL] [Abstract][Full Text] [Related]
3. Sanguinarine as a new chemical entity of thioredoxin reductase inhibitor to elicit oxidative stress and promote tumor cell apoptosis.
Yao J; Duan D; Song ZL; Zhang J; Fang J
Free Radic Biol Med; 2020 May; 152():659-667. PubMed ID: 31931095
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
5. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase.
Zhang J; Yao J; Peng S; Li X; Fang J
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):129-138. PubMed ID: 27777067
[TBL] [Abstract][Full Text] [Related]
6. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
7. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
8. Brain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption.
Lopert P; Patel M
Redox Biol; 2014; 2():667-72. PubMed ID: 24936441
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel organoarsenicals as robust thioredoxin reductase inhibitors for oxidative stress mediated cancer therapy.
She W; Shi X; Liu T; Liu Y; Liu Y
Biochem Pharmacol; 2023 Dec; 218():115908. PubMed ID: 37931662
[TBL] [Abstract][Full Text] [Related]
10. Oridonin Induces Oxidative Stress-mediated Cancer Cells Apoptosis
Duan D; Feng X; Pan D; Wang L; Wang Y; Wang X
Curr Pharm Biotechnol; 2022; 23(14):1647-1657. PubMed ID: 34923938
[TBL] [Abstract][Full Text] [Related]
11. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
Montano SJ; Lu J; Gustafsson TN; Holmgren A
Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
[TBL] [Abstract][Full Text] [Related]
12. Methylglyoxal-Induced Protection Response and Toxicity: Role of Glutathione Reductase and Thioredoxin Systems.
Schmitz AE; de Souza LF; Dos Santos B; Maher P; Lopes FM; Londero GF; Klamt F; Dafre AL
Neurotox Res; 2017 Oct; 32(3):340-350. PubMed ID: 28478530
[TBL] [Abstract][Full Text] [Related]
13. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
Huang J; Xu J; Tian L; Zhong L
Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
[TBL] [Abstract][Full Text] [Related]
14. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.
Hashemy SI; Ungerstedt JS; Zahedi Avval F; Holmgren A
J Biol Chem; 2006 Apr; 281(16):10691-7. PubMed ID: 16481328
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin system in cell death progression.
Lu J; Holmgren A
Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
[TBL] [Abstract][Full Text] [Related]
17. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Thioredoxin System as a Strategy for Cancer Therapy.
Bian M; Fan R; Zhao S; Liu W
J Med Chem; 2019 Aug; 62(16):7309-7321. PubMed ID: 30963763
[TBL] [Abstract][Full Text] [Related]
19. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.
Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y
Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520
[TBL] [Abstract][Full Text] [Related]
20. Revival of glutathione reductase in human cataractous and clear lens extracts by thioredoxin and thioredoxin reductase, in conjunction with alpha-crystallin or thioltransferase.
Yan H; Harding JJ; Xing K; Lou MF
Curr Eye Res; 2007 May; 32(5):455-63. PubMed ID: 17514531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
